~ 17 ~
International Journal of Applied Dental Sciences
Fig 12: Preoperative and postoperative comparison after six months
Discussion
Gingival fibromatosis may be congenital or hereditary, the
causes of which are not clearly understood. Hence, the terms
idiopathic gingival fibromatosis and hereditary gingival
fibromatosis are often used interchangeably
[14]
.
Fibrotic gingival enlargement can also occur after long
duration therapy with drugs like phenytoin
[6]
cyclosporine
[5]
,
nifedipine
[4]
. Hence use of these drugs should be ruled out.
Gingival fibromatosis may be associated with physical
development, retardation, and hypertrichosis
[3]
. Enlargement
usually begins with the eruption of the permanent dentition
but can develop with the eruption of the deciduous dentition;
rarely it may be present at birth or arise in adulthood
[16]
.
Maximal enlargement occurs either during loss of deciduous
teeth or in the early stages of eruption of permanent teeth and
progresses rapidly during "active" eruption and decreases
with the end of this stage
11
. It has been suggested that gingival
enlargement may be due to nutritional and hormonal factors;
however, these have not been completely substantiated. The
constant increase in the tissue mass can result in delayed
eruption and displacement of teeth, arch deformity, spacing,
and migration of teeth
[12]
. All these features may create
problem in normal mastication and in oral hygiene measures.
Maintaining good oral hygiene is important as the presence of
inflammation and infection can be associated with a risk of
recurrence of the gingival enlargement. However, gingival
fibromatosis recurrence is not only due to the presence of
local factors, but also due to genetic predisposition.
Therefore, it is not possible to predict the long-term results of
gingival fibromatosis treatment even when associated with
good oral hygiene.
Histologically, the gingival fibromatosis is mainly due to an
increase in numbers of fibroblast in the connective tissue
stroma. The nodular appearance can be attributed to the
hyperkeratinized epithelium. The treatment of choice in this
condition was gingivectomy as bony intervention was not
required. Since recurrence can occur within a few months
after surgery and may return to the original condition within
few years, the patient may have to undergo repeated
gingivectomy procedures. However, in this patient there was
no sign of recurrence for the six months follow up period.
Conclusion
Therefore, long-term follow-up is mandatory for maintenance
and to evaluate the predictability of the surgical treatment and
the recurrence of the gingival enlargement. IGE is an
enlargement of genetic predisposition and unknown etiology
and hence the rate of recurrence is very high impending the
normal functions and esthetics of the patient.
References
1. Newman, Takei, Klokkevold, Carranza. Carranza’s
clinical periodontology. Twelfth edition.
2. Thomas D, Rapley J, Strathman R, Parker R. Tuberous
sclerosis with gingival overgrowth. J Periodontol. 1992;
63:713-7.
3. Horning GM, Fisher JG, Barker BF, Killoy WJ, Lowe
JW. Gingival fibromatosis with hypertrichosis: A case
report. J Periodontol. 1985; 56:344-7.
4. Heijl L, Sundin Y. Nitrendipine-induced gingival
overgrowth in dogs. J Periodontol. 1989; 60:104-12.
5. Thomason JM, Seymour RA, Ellis JS, Kelly PJ, Parry G,
Dark J et al. Determinants of gingival overgrowth
severity in organ transplant patients: An examination of
the role of HLA phenotype. J Clin Periodontol. 1996;
23:628-34.
6. Kato T, Okahashi N, Kawai S, Kato T, Inaba H, Morisaki
I et al. Impaired degradation of matrix collagen in human
gingival fibroblasts by the antiepileptic drug phenytoin. J
Periodontol. 2005; 76:941-50.
7. Holzhausen M, Ribeiro FS, Gonçalves D, Correa FO,
Spolidorio LC, Orrico SR. Treatment of gingival
fibromatosis associated with Zimmermann-Laband
syndrome. J Periodontol. 2005; 76:1559-62.
8. Wynne SE, Aldred MJ, Bartold PM. Hereditary gingival
fibromatosis associated with hearing loss and
supernumerary teeth: A new syndrome. J Periodontol.
1995; 66:75-9.
9. Piattelli A, Scarano A, Di Bellucci A, Matarasso S.
Juvenile hyaline fibromatosis of gingiva: A case report. J
Periodontol. 1996; 67:451-3.
10. Cross HE, McKusick VA, Breen W. A new oculocerebral
syndrome with hypopigmentation. J Pediatr. 1967;
70:398-406.
11. Ramon Y, Berman W, Bubis JJ. Gingival fibromatosis
combined with cherubism. Oral Surg Oral Med Oral
Pathol. 1967; 24:435-48.
12. Harrison M, Odell EW, Agrawal M, Saravanamuttu R,
Longhurst P. Gingival fibromatosis with prune‑ belly
syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod. 1998; 86:304-7.
13. Hart TC, Pallos D, Bozzo L, Almeida OP, Marazita ML,
O’Connell JR, et al. Evidence of genetic heterogeneity
for hereditary gingival fibromatosis. J Dent Res. 2000;
79:1758-64.
14. Arvind Shetty, Neha Gupta, Devanand Shetty, Rukshit
Kadakia. Idiopathic gingival enlargement associated with
generalized aggressive periodontitis in a 19‑ year‑ old
female. Journal of Indian Society of Periodontology.